News | Heart Failure | November 21, 2022

Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology

Cardiovascular disease remains the leading cause of death in the United States (US) and worldwide, according to the American Heart Association.

November 21, 2022 — Cardiovascular disease remains the leading cause of death in the United States (US) and worldwide, according to the American Heart Association. With risk factors for cardiovascular disease such as obesity and type 2 diabetes on the rise in the US, the field of cardiovascular medicine finds itself in need of a paradigm shift to improve the cardiovascular health of our nation. 

In a concerted effort to move the needle, clinicians specializing in the prevention of cardiovascular disease, along with the American Society for Preventive Cardiology (ASPC), are rapidly growing the subspecialty referred to commonly as "preventive cardiology". 

 "The importance of cardiovascular disease prevention has never been more urgent for the United States and the world." shares President of the ASPC, Dr. Martha Gulati. "Changing our focus from 'sick care' to true 'health care' starts with cardiovascular disease prevention, and this will be led by preventive cardiologists. This important statement from ASPC should serve as a guide to our cardiology community towards an approach to improve the heart health of our patients." 

Recently published in the American Journal of Preventive Cardiology, this clinical practice statement endorsed by the ASPC delineates the key attributes that define the field of preventive cardiology. Lead author, Charles German, MD shares the importance of this publication: "Despite concerted efforts, high rates of cardiovascular diseases continue to plague our society. Preventive cardiologists are needed now more than ever to help improve the cardiovascular health of our population, and we hope this statement helps bring clarity and unity to the field." 

For more information: https://www.sciencedirect.com/science/article/pii/S2666667722001167  


Related Content

Feature | Heart Failure | Kyle Hardner

Editor's Note: This is Part Three of a three-part series highlighting several of the presentations from the American ...

Home May 13, 2026
Home
News | Heart Failure

May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...

Home May 11, 2026
Home
Feature | Heart Failure | Kyle Hardner

Could a link between the heart, brain and immune system help reduce the occurrence of heart attacks and lessen the ...

Home May 04, 2026
Home
News | Heart Failure

April 21, 2026 — Nuwellis, Inc. has announced a software update to its Aquadex SmartFlow ultrafiltration platform. The ...

Home April 23, 2026
Home
News | Heart Failure

March 28, 2026 — Amgen announced today that Repatha (evolocumab), when added to statins or other low-density lipoprotein ...

Home April 06, 2026
Home
News | Heart Failure

March 24, 2026 — New research shows that small improvements to sleep, diet quality and physical activity, made in ...

Home March 25, 2026
Home
News | Heart Failure

March 16, 2026 — Cytokinetics has announced four presentations related to Myqorzo (aficamten) at the American College of ...

Home March 16, 2026
Home
Feature | Heart Failure | Rohit Sood, MD, PhD

Cardiovascular disease (CVD) is a serious global health burden that encompasses a broad group of diseases that affect ...

Home February 12, 2026
Home
News | Heart Failure

Feb. 3, 2026 — Bristol Myers Squibb has launched "Change the Target. Change What’s Possible," an educational campaign ...

Home February 03, 2026
Home
News | Heart Failure

Jan. 27, 2026 — A new national study reveals a stark disconnect between Americans’ desire for preventive cardiac ...

Home January 27, 2026
Home
Subscribe Now